{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 19, "transaction_limit": 160, "filters": {"q": "", "ticker": "RLAY", "sector": "", "industry": "", "side": "", "start": "2026-06-18", "end": "2026-08-02"}, "summary": {"total": 19, "acquisition_count": 6, "disposal_count": 13, "acquisition_value": 1262185.9, "acquisition_value_label": "$1.3M", "disposal_value": 7151405.18, "disposal_value_label": "$7.2M", "net_value": -5889219.28, "net_value_label": "$-5.9M", "flow_tone": "negative", "largest_value_label": "$1.6M", "top_sector": "Healthcare", "window_label": "18 Jun 2026 to 02 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 19, "value": "8413591.0800", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$8.4M"}], "days": [{"transaction_date": "2026-06-22", "acquisitions": 4, "disposals": 9, "total": 13, "bar_width": 100.0}, {"transaction_date": "2026-06-30", "acquisitions": 2, "disposals": 1, "total": 3, "bar_width": 23.1}, {"transaction_date": "2026-07-06", "acquisitions": 0, "disposals": 2, "total": 2, "bar_width": 15.4}, {"transaction_date": "2026-07-07", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 7.7}], "side_mix": {"acquisitions": 6, "disposals": 13, "acquisition_share": 31.6, "disposal_share": 68.4}}, "company_flows": [{"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-07", "acquisitions": 6, "disposals": 13, "acquired_value": 1262185.9, "acquired_value_label": "$1.3M", "disposed_value": 7151405.18, "disposed_value_label": "$7.2M", "net_value": -5889219.28, "net_value_label": "$-5.9M", "acquisition_share": 31.6, "disposal_share": 68.4, "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}], "company_overview": [{"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-07", "filings": 19, "acquisitions": 6, "disposals": 13, "acquired_value": 1262185.9, "acquired_value_label": "$1.3M", "disposed_value": 7151405.18, "disposed_value_label": "$7.2M", "net_value": -5889219.28, "net_value_label": "$-5.9M", "acquisition_share": 31.6, "disposal_share": 68.4, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}], "transactions": [{"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "PATEL, SANJIV", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 48199.0, "share_price": 19.58, "transaction_value": 943736.42, "fetched_at": "2026-07-27T11:13:16.999603+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "CATINAZZO, THOMAS", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 17717.0, "share_price": 18.69, "transaction_value": 331130.73, "fetched_at": "2026-07-27T11:13:17.011953+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "BERGSTROM, DONALD A", "executive_title": "President, R&D", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 8660.0, "share_price": 18.71, "transaction_value": 162028.6, "fetched_at": "2026-07-27T11:13:17.015082+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "RAHMER, PETER", "executive_title": "See remarks", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 50000.0, "share_price": 19.09, "transaction_value": 954500.0, "fetched_at": "2026-07-20T11:08:28.687945+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "PATEL, SANJIV", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3056.0, "share_price": 6.95, "transaction_value": 21239.2, "fetched_at": "2026-07-20T11:08:28.684295+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "RAHMER, PETER", "executive_title": "See remarks", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3056.0, "share_price": 6.95, "transaction_value": 21239.2, "fetched_at": "2026-07-20T11:08:28.686085+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "BERGSTROM, DONALD A", "executive_title": "President, R&D", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 93456.0, "share_price": 16.94, "transaction_value": 1583144.64, "fetched_at": "2026-07-13T11:10:10.433767+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "CATINAZZO, THOMAS", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 61563.0, "share_price": 16.97, "transaction_value": 1044724.11, "fetched_at": "2026-07-13T11:10:10.448835+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "CATINAZZO, THOMAS", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 56323.0, "share_price": 16.97, "transaction_value": 955801.31, "fetched_at": "2026-07-13T11:10:10.453579+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "CATINAZZO, THOMAS", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 51560.0, "share_price": 16.97, "transaction_value": 874973.2, "fetched_at": "2026-07-13T11:10:10.445136+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "BERGSTROM, DONALD A", "executive_title": "President, R&D", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 93456.0, "share_price": 4.12, "transaction_value": 385038.72, "fetched_at": "2026-07-13T11:10:10.436710+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "CATINAZZO, THOMAS", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 61563.0, "share_price": 5.22, "transaction_value": 321358.86, "fetched_at": "2026-07-13T11:10:10.450924+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "CATINAZZO, THOMAS", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 17717.0, "share_price": 17.01, "transaction_value": 301366.17, "fetched_at": "2026-07-13T11:10:10.455251+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "CATINAZZO, THOMAS", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 56323.0, "share_price": 5.04, "transaction_value": 283867.92, "fetched_at": "2026-07-13T11:10:10.457061+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "CATINAZZO, THOMAS", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 51560.0, "share_price": 4.45, "transaction_value": 229442.0, "fetched_at": "2026-07-13T11:10:10.446845+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "BERGSTROM, DONALD A", "executive_title": "President, R&D", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 93456.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T11:10:10.459241+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "CATINAZZO, THOMAS", "executive_title": "Chief Financial Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 61563.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T11:10:10.441593+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "CATINAZZO, THOMAS", "executive_title": "Chief Financial Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 51560.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T11:10:10.439005+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}, {"symbol": "RLAY", "name": "Relay Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "CATINAZZO, THOMAS", "executive_title": "Chief Financial Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 56323.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T11:10:10.443336+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rlay/", "research_links": {"chart": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/", "report": "/terminal/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/report/", "factor": "/factors/ticker/68968c7d-40fa-4e2e-a6be-6c57dd40fc8d/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}